U.S. Markets closed

Kymera Therapeutics, Inc. (KYMR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
58.15+0.77 (+1.34%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts7777
Avg. Estimate-0.26-0.22-1.23-1.67
Low Estimate-0.42-0.45-1.66-2.96
High Estimate-0.080.26-0.62-0.46
Year Ago EPSN/A-0.39-3.15-1.23
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts6688
Avg. Estimate18.81M19.29M82.21M76.58M
Low Estimate15M15M61M30M
High Estimate22M23.5M137M120M
Year Ago SalesN/A18M34.03M82.21M
Sales Growth (year/est)N/A7.20%141.60%-6.80%
Earnings HistoryInvalid Date9/29/202012/30/20203/30/2021
EPS Est.N/A-0.21-0.04-0.15
EPS ActualN/A-0.39-0.29-0.29
DifferenceN/A-0.18-0.25-0.14
Surprise %N/A-85.70%-625.00%-93.30%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.26-0.22-1.23-1.67
7 Days Ago-0.26-0.22-1.23-1.67
30 Days Ago-0.26-0.22-1.23-1.67
60 Days Ago-0.17-0.14-1.06-1.76
90 Days Ago-0.21-0.25-0.95-1.69
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesKYMRIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.43.60%N/AN/AN/A
Current Year61.00%N/AN/AN/A
Next Year-35.80%N/AN/AN/A
Next 5 Years (per annum)-14.90%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A